Stocks and Investing Stocks and Investing
Mon, August 19, 2019
Fri, August 16, 2019
Thu, August 15, 2019
Wed, August 14, 2019
Tue, August 13, 2019
Mon, August 12, 2019
Fri, August 9, 2019
Thu, August 8, 2019
Wed, August 7, 2019

David Lebovitz Maintained (ALNY) at Buy with Decreased Target to $124 on, Aug 7th, 2019


Published on 2024-10-26 15:24:26 - WOPRAI, David Lebovitz
  Print publication without navigation


David Lebovitz of Morgan Stanley, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Buy with Decreased Target from $126 to $124 on, Aug 7th, 2019.

David has made no other calls on ALNY in the last 4 months.



There are 4 other peers that have a rating on ALNY. Out of the 4 peers that are also analyzing ALNY, 1 agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Mani Foroohar of "SVB Leerink" Maintained at Hold with Increased Target to $70 on, Tuesday, April 9th, 2019


These are the ratings of the 3 analyists that currently disagree with David


  • Do Kim of "BMO Capital" Maintained at Buy with Increased Target to $128 on, Thursday, May 2nd, 2019
  • Olivia Brayer of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $138 on, Monday, April 15th, 2019
  • Paul Matteis of "Stifel" Maintained at Strong Buy with Increased Target to $116 on, Monday, April 15th, 2019